Nha Cao, OD
Corneal and Contact Management · Scottsdale, AZNPI 1932660974
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $5,543 of the $7,115 with a category attached, or 77.9%. 13 manufacturers reported payments, led by Alcon at 51.1% of the total. Reporting peaked in 2024 at $2,782 and has fallen 61.3% since, to $1,076 in 2025.
Across 130 payments — averaging $54.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon$4K
- Bausch & Lomb Americas Inc.$2K
- Coopervision Inc.$440
- Tarsus Pharmaceuticals, Inc.$415
- Bausch & Lomb, A Division Of Bausch Health US, LLC$218
- Johnson & Johnson Vision Care, Inc.$185
- plus $670 from 7 others
What the payments were for
- Travel & lodging$1,57222%
- Food & beverage$5,54378%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcon | 53 | $3,636 |
| Bausch & Lomb Americas Inc. | 23 | $1,551 |
| Coopervision Inc. | 13 | $440 |
| Tarsus Pharmaceuticals, Inc. | 12 | $415 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 6 | $218 |
| Johnson & Johnson Vision Care, Inc. | 9 | $185 |
| Sun Pharmaceutical Industries Inc. | 3 | $181 |
| Astellas Pharma US Inc | 3 | $161 |
| Oyster Point Pharma, Inc. | 3 | $134 |
| AbbVie | 1 | $125 |
| Dompe US, Inc. | 2 | $38 |
| Kala Pharmaceuticals, Inc. | 1 | $17 |
| Akorn Operating Company LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INFUSE$1,020
- AcrySof$300
- Precision 1$253
- TOTAL30$253
- XDEMVY$247
- INFUSE MULTIFOCAL$148
- DAILIES TOTAL1$140
- Dailies Aqua Comfort Plus Multifocal$140
- Air Optix plus HydraGlyde$140
- CEQUA$125
- VUITY$125
- Izervay$117
- MyDay Contact Lens$115
- Precision7$113
- REVIVE$109
- MIEBO$107
- Clariti Contact Lens$103
How this compares
Too few corneal and contact management providers in Arizonato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluorometholone | 12 | $926 |
| Prednisolone Acetate | 14 | $428 |
| Latanoprost | 14 | $125 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 16 | $110 |
Paid to pharmacies, not to this prescriber.
Other corneal and contact management in Scottsdale
- Caitlin MorrisonScottsdale$90K
- Arthur EpsteinPhoenix$279K
- Brianna RyffGlendale$15K
- David AndersonPhoenix$5K
- Erik BurnettTucson$4K
- Bartholomew PembertonTucson$4K
- Timothy McAuliffePhoenix$3K
- Ljiljana AleksicPhoenix$3K
- Andrew HuttenhoffTucson$1K
- Jeffrey LewisTucson$510
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.